These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris. Zaenglein AL, Shamban A, Webster G, Del Rosso J, Dover JS, Swinyer L, Stein L, Lin X, Draelos Z, Gold M, Thiboutot D. J Drugs Dermatol; 2013 Jun 01; 12(6):619-25. PubMed ID: 23839176 [Abstract] [Full Text] [Related]
3. A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies. Gold LS, Dhawan S, Weiss J, Draelos ZD, Ellman H, Stuart IA. J Am Acad Dermatol; 2019 Jan 01; 80(1):168-177. PubMed ID: 30165171 [Abstract] [Full Text] [Related]
4. Topical Minocycline Foam 4%: A Review in Acne Vulgaris. Paik J. Am J Clin Dermatol; 2020 Jun 01; 21(3):449-456. PubMed ID: 32468355 [Abstract] [Full Text] [Related]
5. Minocycline Topical Foam: A New Drug for the Treatment of Acne. Onge ES, Mobley WC. Ann Pharmacother; 2021 Jan 01; 55(1):105-110. PubMed ID: 32618475 [Abstract] [Full Text] [Related]
6. Topical minocycline foam 4%: Results of four phase 1 studies evaluating the potential for phototoxicity, photoallergy, sensitization, and cumulative irritation. Dosik J, Ellman H, Stuart I. J Immunotoxicol; 2019 Dec 01; 16(1):133-139. PubMed ID: 31179779 [Abstract] [Full Text] [Related]
8. Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: A phase 3 study. Raoof TJ, Hooper D, Moore A, Zaiac M, Sullivan T, Kircik L, Lain E, Jankicevic J, Stuart I. J Am Acad Dermatol; 2020 Apr 01; 82(4):832-837. PubMed ID: 31163231 [Abstract] [Full Text] [Related]
9. Topical minocycline foam for moderate to severe acne vulgaris: Phase 2 randomized double-blind, vehicle-controlled study results. Shemer A, Shiri J, Mashiah J, Farhi R, Gupta AK. J Am Acad Dermatol; 2016 Jun 01; 74(6):1251-2. PubMed ID: 27185426 [No Abstract] [Full Text] [Related]
11. Amzeeq (minocycline foam 4%) for topical treatment of acne vulgaris. Gupta AK, Bruce A, Vincent KD, Abramovits W. Skinmed; 2020 Jun 01; 18(6):354-357. PubMed ID: 33397564 [No Abstract] [Full Text] [Related]
12. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. Leyden J, Thiboutot DM, Shalita AR, Webster G, Washenik K, Strober BE, Shupack J. Arch Dermatol; 2006 May 01; 142(5):605-12. PubMed ID: 16702498 [Abstract] [Full Text] [Related]
13. Evaluating FMX-101 as a promising therapeutic for the treatment of acne. Valente Duarte de Sousa IC. Expert Opin Pharmacother; 2020 May 01; 21(7):741-746. PubMed ID: 32037906 [Abstract] [Full Text] [Related]